Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 153 results found since Jan 2013.

Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-controlled Case Series, and Population Time Trend Studies.
This study with nationwide coverage showed no evidence of a causal link between HPV vaccination and diffuse autonomic symptoms leading to hospital contact. PMID: 31899791 [PubMed - as supplied by publisher]
Source: Am J Epidemiol - January 2, 2020 Category: Epidemiology Authors: Thomsen RW, Öztürk B, Pedersen L, Nicolaisen SK, Petersen I, Olsen J, Sørensen HT Tags: Am J Epidemiol Source Type: research

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.
CONCLUSIONS: Certain conditions are prevalent in the same patient populations that are vaccinated with the HPV vaccine (peri-pubertal males and females). This association, however, is insufficient proof of causality. PMID: 31928708 [PubMed - in process]
Source: Autonomic Neuroscience - December 31, 2019 Category: Neuroscience Authors: Barboi A, Gibbons CH, Axelrod F, Benarroch EE, Biaggioni I, Chapleau MW, Chelimsky G, Chelimsky T, Cheshire WP, Claydon VE, Freeman R, Goldstein DS, Joyner MJ, Kaufmann H, Low PA, Norcliffe-Kaufmann L, Robertson D, Shibao CA, Singer W, Snapper H, Vernino Tags: Auton Neurosci Source Type: research

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society
Human papillomavirus (HPV) vaccination has been anecdotally connected to development of dysautonomia, chronic fatigue, complex regional pain syndrome and postural tachycardia syndrome.
Source: Autonomic Neuroscience: Basic and Clinical - December 31, 2019 Category: Neuroscience Authors: Alexandru Barboi, Christopher H. Gibbons, Felicia Axelrod, Eduardo E. Benarroch, Italo Biaggioni, Mark W. Chapleau, Gisela Chelimsky, Thomas Chelimsky, William P. Cheshire, Victoria E. Claydon, Roy Freeman, David S. Goldstein, Michael J. Joyner, Horacio K Source Type: research

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
CONCLUSIONS: The immunogenicity of two-dose and three-dose HPV vaccine schedules, measured using antibody responses in young females, is comparable. The quadrivalent vaccine probably reduces external genital lesions and anogenital warts in males compared with control. The nonavalent and quadrivalent vaccines offer similar protection against a combined outcome of cervical, vaginal, and vulval precancer lesions or cancer. In people living with HIV, both the bivalent and quadrivalent HPV vaccines result in high antibody responses. For all comparisons of alternative HPV vaccine schedules, the certainty of the body of evidence ...
Source: Cochrane Database of Systematic Reviews - November 21, 2019 Category: General Medicine Authors: Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N Tags: Cochrane Database Syst Rev Source Type: research

New Cochrane Review assesses different HPV vaccines and vaccine schedules in adolescent girls and boys
New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus (HPV) vaccines and vaccine schedules in young women and men.HPV is the most common viral infection of the reproductive tract in both women and men globally (WHO 2017). Most people who have sexual contact will be exposed to HPV at some point in their life. In most people, their own immune system will clear the HPV infection.HPV infection can sometimes persist if the immune system does not clear the virus. Persistent infection with some ‘high-risk’ strains of HPV can lead to the de...
Source: Cochrane News and Events - November 20, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data.
Conclusion: The results support the safety and continued administration of HPV vaccines to adolescents. PMID: 31674255 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - November 3, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society
ConclusionCertain conditions are prevalent in the same populations that are vaccinated with the HPV vaccine (peri-pubertal males and females). This association, however, is an insufficient proof of causality.
Source: Clinical Autonomic Research - September 1, 2019 Category: Research Source Type: research

HPV vaccine: A vaccine that works, and one all children should get
Human papillomavirus, or HPV, is the most common sexually transmitted infection. Most of the time, the body clears it without problems. But when it doesn’t, it can lead to cancer. HPV is the leading cause of cervical cancer, and it can also lead to cancers of the vagina, vulva, penis, anus, and mouth. Every year, there are more than 40,000 cases of cancer caused by HPV. The HPV vaccine can prevent most of them. Research shows the HPV vaccine is effective A study published in the journal Pediatrics underlined just how effective the vaccine is. Researchers studied women ages 13 to 26 between 2006 and 2017, looking at thei...
Source: Harvard Health Blog - July 26, 2019 Category: Consumer Health News Authors: Claire McCarthy, MD Tags: Children's Health Men's Health Parenting Vaccines Women's Health Source Type: blogs

Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016
Conclusions South Korea should develop a system for proactively updating HPV  labels. These results also suggest potential research directions such as vaccination label expansion, pharmacovigilance studies, and identification of causality in AEs associated with HPV vaccination.
Source: International Journal of Clinical Pharmacy - July 15, 2019 Category: Drugs & Pharmacology Source Type: research

A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017.
ConclusionsNon-specific symptoms including headache, fatigue and dizziness feature prominently in serious AE reports from females in Denmark. Our analysis identified a cluster of reports, likely media stimulated, with a focus on symptoms of CFS and POTS. PMID: 31088598 [PubMed - in process]
Source: Euro Surveill - April 30, 2019 Category: Infectious Diseases Authors: Ward D, Thorsen NM, Frisch M, Valentiner-Branth P, Mølbak K, Hviid A Tags: Euro Surveill Source Type: research

Post Marketing Surveillance Study of 2nd Dose Quadrivalent Human Papilloma Virus Vaccine in Elementary School Children in Jakarta, Indonesia: Safety Result and Implementation of School-Based HPV Immunization Program
Conclusion: These results along with the safety data from the pre-licensure clinical trials confirm the favorable safety profile of QHPV vaccine in pre-adolescent girls. The school-based two-dose QHPV immunization program in Indonesia is a safe and effective strategy for optimizing HPV vaccine coverage among pre-adolescent girls. PMID: 30912406 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - March 27, 2019 Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research

Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
CONCLUSIONS: Results suggest qHPV vaccine is efficacious against HPV6/11/16/18-related persistent infections, immunogenic, and well-tolerated in Japanese men. Clinical trial registration identifier: NCT01862874. PMID: 30797638 [PubMed - as supplied by publisher]
Source: Vaccine - February 20, 2019 Category: Allergy & Immunology Authors: Mikamo H, Yamagishi Y, Murata S, Yokokawa R, Han SR, Wakana A, Sawata M, Tanaka Y Tags: Vaccine Source Type: research

An Integrative Review of the Influences on Decision-Making of Young People About Human Papillomavirus Vaccine.
Abstract The human papillomavirus (HPV) vaccine is a key intervention in the prevention of HPV infection and associated cancers. This review emphasizes the importance of understanding what influences decision-making about this vaccine. Guided by the work of Whittemore and Knafl, and Pluye and Hong, we identified 25 studies, from which four prominent themes emerged: fear and risk, pain, parental involvement, and involvement of others. Fear of cervical cancer was a strong motivation to receive the vaccine, and the extent of parental involvement also had an impact on decision-making. Recommendations to receive the va...
Source: The Journal of School Nursing - October 15, 2018 Category: Nursing Authors: Sisson H, Wilkinson Y Tags: J Sch Nurs Source Type: research

Africa:Stopping Cervical Cancer and Other Noncommunicable Diseases in Africa
[WHO] As she felt the cold sting of the needle enter her arm, Alice winced in fear more than pain- understandable as she is only 10. However, a moment of pain could save her from the leading cause of cancer death among women in Africa: cervical cancer. She is receiving a vaccine against human papilloma virus (HPV), the main gateway agent in cervical cancer.
Source: AllAfrica News: Health and Medicine - September 12, 2018 Category: African Health Source Type: news

Adverse Event Reporting Patterns of Marketing Authorization Holders, Healthcare Professionals and Patients in Japan: Lessons Learnt From the Human Papilloma Virus Vaccine
ConclusionIn Japan, the characteristics of AEFI reports differed by source for HPV vaccines. MAH and HCP reports identified the major trend in AEFI occurrence during the early post-marketing phase, whereas patient reports in cooperation with HCPs facilitated the detection of weak signals of possible AEFIs throughout the product lifecycle. Patient reporting systems should be encouraged, especially by promoting the communication between patients and  local “home” pharmacies in cooperation with patient organizations.
Source: Pharmaceutical Medicine - March 19, 2018 Category: Drugs & Pharmacology Source Type: research